Merck KGaA sets its sights on acquisition of Ogsiveo-maker SpringWorks: Reuters
Merck KGaA is said to be in advanced talks to acquire cancer and are disease specialist SpringWorks, which has a market value of around $3 billion, Reuters reported Monday, citing people close to the matter. Should everything go to plan, the deal could be inked in the coming weeks.
Merck KGaA is said to be in advanced talks to acquire cancer and are disease specialist SpringWorks, which has a market value of around $3 billion, Reuters reported Monday, citing people close to the matter. Should everything go to plan, the deal could be inked in the coming weeks.
